A Multicenter, Single-arm, Prospective Study to Evaluate the Efficacy and Safety of Radiotherapy Combined With Ripretinib in the Treatment of Unresectable Advanced GIST
Latest Information Update: 25 Jul 2024
At a glance
- Drugs Ripretinib (Primary)
- Indications Gastrointestinal stromal tumours
- Focus Therapeutic Use
Most Recent Events
- 25 Jul 2024 New trial record